| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |